Insider Trading Arrangements |
3 Months Ended |
|---|---|
|
Sep. 30, 2026
shares
| |
| Trading Arrangements, by Individual | |
| Non-Rule 10b5-1 Arrangement Adopted | false |
| Rule 10b5-1 Arrangement Terminated | false |
| Non-Rule 10b5-1 Arrangement Terminated | false |
| Ilya Yuffa [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On September 3, 2026, Ilya Yuffa, executive vice president and president Lilly USA and Global Customer Capabilities, adopted a sales plan (Yuffa Plan). The Yuffa Plan provides for the sale of up to 1,000 shares of company common stock and expires on February 10, 2027, subject to earlier termination in accordance with its terms.
|
| Name | Ilya Yuffa |
| Title | executive vice president |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | September 3, 2026 |
| Expiration Date | February 10, 2027 |
| Arrangement Duration | 160 days |
| Aggregate Available | 1,000 |
| Jacob Van Naarden [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On September 8, 2026, Jacob Van Naarden, executive vice president, president of Lilly Oncology and head of corporate business development, adopted a sales plan (Van Naarden Plan). The Van Naarden Plan provides for the sale of up to 7,064 shares of company common stock and expires on February 10, 2027, subject to earlier termination in accordance with its terms.
|
| Name | Jacob Van Naarden |
| Title | executive vice president |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | September 8, 2026 |
| Expiration Date | February 10, 2027 |
| Arrangement Duration | 155 days |
| Aggregate Available | 7,064 |
| Anat Hakim [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On September 8, 2026, Anat Hakim, executive vice president, general counsel and secretary, adopted a sales plan (Hakim Plan). The Hakim Plan provides for the sale of up to 22,591 shares of company common stock and expires on February 10, 2027, subject to earlier termination in accordance with its terms.
|
| Name | Anat Hakim |
| Title | executive vice president |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | September 8, 2026 |
| Expiration Date | February 10, 2027 |
| Arrangement Duration | 155 days |
| Aggregate Available | 22,591 |
| Edgardo Hernandez [Member] | |
| Trading Arrangements, by Individual | |
| Material Terms of Trading Arrangement | On September 14, 2026, Edgardo Hernandez, executive vice president and president, manufacturing operations, adopted a sales plan (Hernandez Plan). The Hernandez Plan provides for the sale of up to 1,350 shares of company common stock and expires on February 9, 2028, subject to earlier termination in accordance with its terms.
|
| Name | Edgardo Hernandez |
| Title | executive vice president |
| Rule 10b5-1 Arrangement Adopted | true |
| Adoption Date | September 14, 2026 |
| Expiration Date | February 9, 2028 |
| Arrangement Duration | 513 days |
| Aggregate Available | 1,350 |